Malaria drug could combat chemotherapy-resistant head and neck cancers, research suggests
A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects of cisplatin in animal models.
Materials provided by University of Pittsburgh. Note: Content may be edited for style and length.
Source link aaaaa